HPV testing and Pap test market: Size, Growth And Market Analysis
Human papillomavirus: Human papillomavirus or HPVs are called mucosal because they infect live cells on mucosal surfaces. Cervical cancer can be prevented by detecting and treating abnormal cells that grow in the cervix. HPV and Pap tests are the two most popular tests used to examine the activity of cervical cells. Market Analysis: From USD 3.29 billion in 2015 to USD 4.52 billion in 2020, the global HPV testing and Pap test market is expected to grow at a CAGR of 6.6 percent. Cervical cancer is the second most frequent cancer in women, coming in second only to breast cancer. Cervical cancer is caused by HPV, a sexually transmitted virus that has been scientifically confirmed to be the primary cause. Around 90% of all anal and cervical cancers, as well as 70% of vaginal and vulvar cancers, are caused by HPV. Cervical cancer is most commonly detected via Pap testing. One of these tests is the microscopic examination of specimens. These tests, however, are unable to detect all genotype